acetylglucosamine has been researched along with thymoquinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebeid, EM; El-Ashmawy, NE; Khedr, EG; Mosalam, EM; Salem, ML; Zidan, AA | 2 |
2 other study(ies) available for acetylglucosamine and thymoquinone
| Article | Year |
|---|---|
Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
Topics: Acetylglucosamine; Animals; Antibiotics, Antineoplastic; Benzoquinones; Carcinoma, Ehrlich Tumor; Chemotherapy, Adjuvant; Creatine Kinase; Creatine Kinase, MB Form; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Genes, p53; L-Lactate Dehydrogenase; Malondialdehyde; Mice; Microscopy, Electron, Transmission; Myocardium; Nanostructures; Proto-Oncogene Proteins c-bcl-2; Tumor Burden | 2017 |
Loading of doxorubicin and thymoquinone with F2 gel nanofibers improves the antitumor activity and ameliorates doxorubicin-associated nephrotoxicity.
Topics: Acetylglucosamine; Animals; Antineoplastic Agents; Antioxidants; Apoptosis; Benzoquinones; Biomarkers; Caspase 3; Cell Survival; Doxorubicin; Drug Delivery Systems; Female; Hep G2 Cells; Humans; Kidney; Liver Neoplasms; MCF-7 Cells; Mice; Nanofibers; Neoplasms, Experimental; Oxidative Stress; Particle Size | 2018 |